Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1364 results

Improving your patient's outcomes with the Edwards Benchmark program

18 May 2021 – From EuroPCR 2021

Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...

Improving your patient's outcomes with the Edwards Benchmark program

Complete 2-year follow-up from the Evolut low risk trial

18 May 2021 – From EuroPCR 2021

This session was originally presented during EuroPCR 2021.

Complete 2-year follow-up from the Evolut low risk trial

Introducing Navitor: a new TAVI solution

18 May 2021 – From EuroPCR 2021

Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...

Introducing Navitor: a new TAVI solution

Planning for a long run: life-time management of bioprosthetic valve implantation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan Windecker, Anna Sonia Petronio, Mohamed Abdel-Wahab, Lars Sondergaard and Hendrik Treede in order to learn about life-time management strategies of aortic stenosis patients, to discuss evolving multifactorial aspects that influence the choice of aortic stenosis patient treatment, and to explore THV...

Planning for a long run: life-time management of bioprosthetic valve implantation

TAVI in a patient with coronary artery disease - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.

This session was originally presented during EuroPCR 2021.

TAVI in a patient with coronary artery disease

PCI in a patient with prior TAVI - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.

This session was originally presented during EuroPCR 2021.

PCI in a patient with prior TAVI

PCR's Got Talent - Valvular Interventions

18 May 2021 – From EuroPCR 2021

Thanks to the abstracts of this session, find out more about heterotopic caval valve implantation preprocedural assessment, patient-specific computer simulation to predict long-term outcomes after TAVI, and much more!

PCR's Got Talent - Round 2: Valvular Interventions

EuroPCR 2021 - Innovations in TAVI

18 May 2021 – From EuroPCR 2021

In this session, find out more about an innovative active sealing cuff providing a new strategy to mitigate PVL, post-implantation CT scans to print patient-specific 3D models, transcatheter antiembolic filter, and much more!

EuroPCR 2021 - Innovations in TAVI

Challenging TAVI cases

18 May 2021 – From EuroPCR 2021

In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.

Challenging TAVI cases

A low-risk patient with a bicuspid type 0 aortic stenosis

18 May 2021 – From EuroPCR 2021

How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!

A low-risk patient with a bicuspid type 0 aortic stenosis

Next-generation TAVR device will enable lifetime management of aortic stenosis patients

18 May 2021 – From EuroPCR 2021

Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...

Next-generation TAVR device will enable lifetime management of aortic stenosis patients

Efficient TAVI in the context of expanding indications?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard and Didier Tchetche in order to review latest data from the Evolut low-risk trial and the OptimizePro study, to learn more about latest TAVI patient pathway efficiency and economics evidence, and to discover how to translate these insights locally and enable you...

Efficient TAVI in the context of expanding indications?

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

EAPCI-PCR Fellows Course 2021 - Valvular track : Self Expandable Valves and complex anatomies

12 May 2021 – From EuroPCR 2021

This episode will give you tips on Self Expandable Valves and complex anatomies - don't miss it !

Key questions:

  • How to assess a bicuspid or a severely calcified aortic valve on CT scan?
  • How to position a self-expanding valve in different anatomies?
  • What are the specificities of valve-in-valve procedures?

The...

EAPCI-PCR Fellows Course 2021 Replay available - Self Expandable Valves and complex anatomies

Left heart suffering after successful TAVI

12 May 2021 – From EuroPCR 2021

In this session, analyze a rare case of cardiogenic shock after TAVR, get prepared in case of Takotsubo cardiomyopathy after transcatheter aortic valve-in-valve replacement, get hints for troubleshooting in treating left-sided obstructions, find out more about transfemoral TAVI and mitral clipping for prevention of a SAM-phenomenon, and more!

EuroPCR 2021 Left heart suffering after successful TAVI

TAVI-in-Bioprostheses - never a dull moment

12 May 2021 – From EuroPCR 2021

In this session, observe degenerated biologic surgical valve fracturing after TAVI implantation, analyze aortic valve-in-valve on a complex vascular anatomy, learn more about aortic and mitral valves dysfunction after surgical replacement, and even more!

EuroPCR 2021 TAVI-in-Bioprostheses - never a dull moment

Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement

07 May 2021

The current analysis aimed to compare the safety and efficacy of the Edwards Sapien S3 and Medtronic Corevalve. Furthermore, conscious sedation (CS) and local anaesthesia have been reported to reduce adverse events compared to general anaesthesia (GA) in several observational studies, with a lack of randomised...

M. Pighi

Reviewer

Michele Pighi
Impact of anesthesia strategy and valve type on clinical outcomes after TAVR

Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis

03 May 2021

In the PARTNER II trial, a new staging system of extra-aortic valvular cardiac damage is proposed, using 2 D transthoracic echocardiography and its prognostic value. The purpose of this study is to evaluate the prognostic value of such extra-aortic cardiac damage using MDCT in patients undergoing...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Salem Assiri

Reviewer

Salem Assiri
Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis

ST-segment elevation myocardial infarction following transcatheter aortic valve replacement

04 May 2021

The aim of the current study was to determine the clinical characteristics, management and outcomes of STEMI after TAVR.

Elad Asher

Reviewer

Elad Asher
STEMI following TAVR

Coronary protection during TAVI - Many roads lead to Rome

28 Apr 2021 – From EuroPCR 2021

Thanks to this session, become familiar with techniques for left main coronary protection in ViV TAVI, get prepared for challenges of ostial coronary artery stenosis in a patient planned for TAVR, find out more about ViV TAVI with high risk of bilateral ostium occlusion, and more!

EuroPCR 2021 Coronary protection - Many roads lead to Rome